IL183840A0 - Compositions and methods for reducing the transmissivity of illnesses - Google Patents

Compositions and methods for reducing the transmissivity of illnesses

Info

Publication number
IL183840A0
IL183840A0 IL183840A IL18384007A IL183840A0 IL 183840 A0 IL183840 A0 IL 183840A0 IL 183840 A IL183840 A IL 183840A IL 18384007 A IL18384007 A IL 18384007A IL 183840 A0 IL183840 A0 IL 183840A0
Authority
IL
Israel
Prior art keywords
illnesses
transmissivity
compositions
reducing
methods
Prior art date
Application number
IL183840A
Original Assignee
The Quigley Corp
Rosenbloom Richard A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Quigley Corp, Rosenbloom Richard A filed Critical The Quigley Corp
Publication of IL183840A0 publication Critical patent/IL183840A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL183840A 2004-12-14 2007-06-11 Compositions and methods for reducing the transmissivity of illnesses IL183840A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/012,764 US7166435B2 (en) 2001-08-06 2004-12-14 Compositions and methods for reducing the transmissivity of illnesses
PCT/US2005/045218 WO2006065889A2 (en) 2004-12-14 2005-12-14 Compositions and methods for reducing the transmissivity of illnesses

Publications (1)

Publication Number Publication Date
IL183840A0 true IL183840A0 (en) 2007-10-31

Family

ID=36588501

Family Applications (1)

Application Number Title Priority Date Filing Date
IL183840A IL183840A0 (en) 2004-12-14 2007-06-11 Compositions and methods for reducing the transmissivity of illnesses

Country Status (12)

Country Link
US (2) US7166435B2 (en)
EP (1) EP1825007A4 (en)
JP (1) JP2008523153A (en)
KR (1) KR20070102487A (en)
CN (1) CN101111608A (en)
AU (1) AU2005317104A1 (en)
CA (1) CA2590340A1 (en)
IL (1) IL183840A0 (en)
MX (1) MX2007007075A (en)
NZ (1) NZ555778A (en)
WO (1) WO2006065889A2 (en)
ZA (1) ZA200704718B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US20100286462A1 (en) * 2002-12-19 2010-11-11 Araba L.L.C. Apparati and Method for Remediating Biologically Active Particles
BRPI0414883A (en) * 2003-09-29 2006-12-12 Ethena Healthcare Inc composition, composition concentrate, and disinfectant and gel-like alcoholic compositions
DE102004062775A1 (en) 2004-12-21 2006-06-29 Stockhausen Gmbh Alcoholic pump foam
KR101455554B1 (en) 2005-03-07 2014-10-27 디이비 월드와이드 헬스케어 인코포레이티드 High alcohol content foaming compositions with silicone-based surfactants
US20060204466A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US7507425B2 (en) * 2005-09-27 2009-03-24 The Quigley Corporation Method for the treatment of cachexia
WO2007046966A2 (en) * 2005-10-13 2007-04-26 Milkhaus Laboratory, Inc Methods for the treatment of influenza
EP1965820A4 (en) * 2005-11-16 2010-01-06 Natbio Pty Ltd Zingiber plant extract
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition
GB0602325D0 (en) * 2006-02-06 2006-03-15 Remedy Res Ltd Virucidal compositions and uses
KR20090097885A (en) * 2006-12-14 2009-09-16 더 퀴글리 코포레이션 Methods for treating and reducing the incidence of newcastle disease
KR20090097886A (en) * 2006-12-14 2009-09-16 더 퀴글리 코포레이션 Compositions and methods for treating infectious bronchitis
KR101481040B1 (en) * 2008-03-31 2015-01-14 한국화학연구원 Composition for anti-inflammation comprising [10]-gingerdione or 1-dehydro-[10]-gingerdione
US20090324734A1 (en) * 2008-06-26 2009-12-31 Daniel Dickey Throat care composition
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
FR2937538B1 (en) * 2008-10-23 2010-12-31 Muselier Corinne Treger ANTIGRIPPAL PRODUCT
US20100183524A1 (en) * 2008-11-26 2010-07-22 Perio Sciences, Llc Antioxidant compositions for soft oral tissue and methods of formulation and use thereof
KR101515822B1 (en) * 2008-11-29 2015-04-29 더 타일랜드 리서치 펀드 Virus and target cell interaction inhibition
US20100151056A1 (en) * 2008-12-16 2010-06-17 Hanan Polansky Dietary supplements for decreasing the latent foreign dna load
US20100178364A1 (en) * 2009-01-12 2010-07-15 Hanan Polansky Dietary supplements against latent foreign DNA
US8906414B1 (en) 2009-04-27 2014-12-09 University Of South Florida Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG)
KR101186264B1 (en) * 2009-06-12 2012-09-27 한국생명공학연구원 A composition for diseases mediated by IL-6 or rhinovirus infectious diseases comprising an extract of Hippophae rhamnoides or a compound isolated therefrom
KR101077920B1 (en) 2009-07-08 2011-10-31 한국생명공학연구원 Composition for prevention and treatment of influenza virus and composition for inhibiting the activity of neuraminidase comprising extracts of Turmeric
WO2011005043A2 (en) * 2009-07-08 2011-01-13 한국생명공학연구원 Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract
US20110052727A1 (en) * 2009-08-31 2011-03-03 Hanan Polansky Anti Influenza Nutritional Supplements
KR101032066B1 (en) * 2009-10-08 2011-05-02 한국생명공학연구원 Pharmaceutical composition for treatment and prevention of common cold comprising extract or fraction from Polygonum Cuspidatum or stilbene compound
ES2553766T3 (en) 2009-10-22 2015-12-11 Maresins Pharma, Inc. Herbicidal compositions comprising ginger and solidarity for the treatment of influenza infection
DK2493491T3 (en) 2009-12-29 2014-06-30 Hills Pet Nutrition Inc COMPOSITIONS, INCLUDING GIFTING FOR THE PURPOSE OR PREVENTION OF INFLAMMATORY CONDITIONS OF CATS AND DOGS
KR101282990B1 (en) * 2011-05-30 2013-07-04 건국대학교 산학협력단 Lipophilic fractions of green tea and green tea by product, and compound from the same with anti-influenza activity
WO2013049507A1 (en) 2011-09-30 2013-04-04 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
CA2903871A1 (en) * 2013-03-15 2014-09-18 Aerpio Therapeutics Inc. Formulations with increased solubility of compounds that activate tie-2
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
NL1040474C2 (en) * 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
AU2014354599A1 (en) * 2013-11-27 2016-06-09 Research Foundation Of The City University Of New York Activity enhancing curcumin compositions and methods of use
CN104013888A (en) * 2014-07-01 2014-09-03 刘德学 Traditional Chinese medicine composition for treating phlegm-heat lung-stagnation type obstructive emphysema and preparation method thereof
US10537548B2 (en) 2014-08-28 2020-01-21 Caliway Biopharmaceuticals Co., Ltd. Composition and medical product for reducing body weight and body fat, and use of said product
KR101923840B1 (en) 2014-08-28 2019-02-27 칼리웨이 바이오파마슈티칼스 코., 엘티디. Composition and medicinal product for reducing body weight and body fat, and use of said product
KR101687337B1 (en) * 2015-06-02 2016-12-16 (주)이엘티사이언스 The composition of foot dip disinfectant for livestock quarantine and method for manufacturing thereof
EP3103465A1 (en) * 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
CN105012831A (en) * 2015-08-05 2015-11-04 李强 Traditional Chinese medicine composition for treating irregular menstruation
US20170360815A1 (en) 2016-02-25 2017-12-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
EP3419629A4 (en) 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
ITUA20161822A1 (en) * 2016-03-18 2017-09-18 Indena Spa USEFUL COMPOSITIONS IN THE PREVENTION AND / OR IN THE TREATMENT OF ORAL CABLE PATHOLOGIES, OF THE FIRST AIRWAYS AND OF THE ESOFAGO
US11123272B2 (en) * 2016-12-02 2021-09-21 Symrise Ag Cosmetic blends
EP3737333B1 (en) * 2018-01-09 2024-05-08 E2Bio Life Sciences, Llc Device for the enhancement of topical treatments for oral mucositis and other oral conditions
EP3714889A1 (en) 2019-03-29 2020-09-30 F. Hoffmann-La Roche AG Baloxavir for the prevention of transmission of influenza virus
KR102224051B1 (en) * 2019-04-04 2021-03-09 한국 한의학 연구원 Composition for enhancing neutralizing antibody generation rate comprising Zingiber officinale extract as effective component
WO2021080388A1 (en) * 2019-10-25 2021-04-29 한국생명공학연구원 Composition for preventing or treating porcine epidemic diarrhea virus infection, comprising complex containing curcuminoid-based compound and licorice extract or fraction thereof
CN111402968B (en) * 2020-04-01 2023-11-03 上海交通大学 New application of kaempferol in COVID-19 virus based on molecular simulation
KR102456749B1 (en) 2020-04-28 2022-10-21 서울대학교산학협력단 Composition for preventing or treating swine influenza virus disease comprising Curcuma longa extract or sesquiterpenoids isolated therefrom as active ingredients
WO2022036316A1 (en) * 2020-08-14 2022-02-17 North Carolina State University Methods to use flavonoids for inhibition of sars-cov-2 and treatment of covid-19
US20220080020A1 (en) * 2020-08-22 2022-03-17 Luc Montagnier Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system
CN113975223A (en) * 2021-08-06 2022-01-28 华中科技大学 Nasal cavity cleaning solution

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2850151B2 (en) 1990-02-02 1999-01-27 日研フード本社株式会社 Antioxidant mineral beverage and method for producing the same
US5120538A (en) 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
SE468893B (en) 1991-09-04 1993-04-05 Tetra Alfa Holdings OPENING DEVICE FOR PACKAGING CONTAINERS
CN1060012A (en) 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 A kind of preparation method of chewing gum
US5248504A (en) 1992-03-02 1993-09-28 Friedman William H Method of treatment for nasal and sinus dysfunction
CN1072823A (en) 1992-06-13 1993-06-09 文士开 The compound method of fruit zymic tea
US6063381A (en) 1993-05-19 2000-05-16 Staggs; Jeff J. Therapeutic uses of pungent botanicals and their related compounds
US5401504B1 (en) 1993-12-28 1998-04-21 Univ Mississippi Medical Cente Use of tumeric in wound healing
CN1116068A (en) 1994-01-25 1996-02-07 刘俊松 Preparing method the main agent of natural emulsified nectar
CA2185825A1 (en) 1994-03-18 1995-09-28 Fujio Suzuki Agent for the treatment of infections
US5494668A (en) 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor
US5707630A (en) 1996-01-04 1998-01-13 Sabina International, Ltd. Herbal compound for relief of PMS through menopausal symptoms
US5861415A (en) 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
JPH11155538A (en) * 1997-11-27 1999-06-15 Uenoya Bikouen:Kk Production of ginger decoction
JP2000157209A (en) 1998-11-27 2000-06-13 Kagetoshi Kawauchi Sprinkling healthy food
US6174542B1 (en) 1999-07-01 2001-01-16 Pms Mood Food, Inc. Dietary supplements and food products for treating symptoms of PMS
US6261607B1 (en) 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6264995B1 (en) 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
US6291533B1 (en) 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type
US6841544B2 (en) 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6274177B1 (en) 2000-08-26 2001-08-14 National Science Council Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract
US6391346B1 (en) 2001-04-05 2002-05-21 Thomas Newmark Anti-inflammatory, sleep-promoting herbal composition and method of use
US6596313B2 (en) 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US7396546B2 (en) * 2001-08-06 2008-07-08 The Quigley Corporation Anti-microbial compositions and methods of using same
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
MXPA05001051A (en) * 2002-08-06 2005-04-08 The Quigley Corp Anti-microbial compositions and methods of using same.

Also Published As

Publication number Publication date
ZA200704718B (en) 2008-11-26
NZ555778A (en) 2009-12-24
US7405046B2 (en) 2008-07-29
US20050147697A1 (en) 2005-07-07
US20070104808A1 (en) 2007-05-10
WO2006065889A2 (en) 2006-06-22
WO2006065889A3 (en) 2006-08-03
CA2590340A1 (en) 2006-06-22
EP1825007A4 (en) 2009-08-05
AU2005317104A1 (en) 2006-06-22
US7166435B2 (en) 2007-01-23
EP1825007A2 (en) 2007-08-29
KR20070102487A (en) 2007-10-18
CN101111608A (en) 2008-01-23
JP2008523153A (en) 2008-07-03
MX2007007075A (en) 2007-09-04

Similar Documents

Publication Publication Date Title
ZA200704718B (en) Compositions and methods for reducing the transmissivity of illnesses
EP1883389A4 (en) Low-irritation compositions and methods of making the same
ZA200802490B (en) Isoindole-imide compounds and compositions comprising and methods of using the same
IL191072A0 (en) Therapeutic compositions and methods
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
PL2057153T3 (en) (3-aryl-piperazin-1-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline
IL182943A0 (en) Ovr110 antibody compositions and methods of use
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
EP1974370A4 (en) Microetching composition and method of using the same
ZA200704295B (en) Arthrospira-based compositions and uses thereof
IL182126A (en) Compositions containing 5-phenoxyalkoxypsoralen derivatives and uses thereof
PT2380573E (en) Eslicarbazepine acetate and methods of use
EP1737458A4 (en) R(-)-11-hydroxyaporphine derivatives and uses thereof
EP1937075A4 (en) Synergistic composition and method of use
PL2215908T3 (en) 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
IL184062A0 (en) Visco-supplement composition and methods
EP1946007A4 (en) Anbrosteeone derivatives and method of use thereof
GB0520930D0 (en) Composition and method of use
ZA200706038B (en) Visco-supplement composition and methods
GB0403696D0 (en) Process and composition
GB0517168D0 (en) Composition and method of use
IL177271A0 (en) Heparanase inhibitors and uses thereof
GB0428034D0 (en) Compositions and methods
ZA200709864B (en) Eslicarbazepine acetate and methods of use